| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |